ABSTRACT
Background: Serum lactate levels are a direct quantification of gap in between energy-expenditure and oxidative capacity. Variation in the lactate levels among the resting individuals could be exigent, requiring attention often and raised lactate levels can be observed among the individuals with mitochondrial impairments in the oxidative phosphorylation pathways. Aim and Objectives: Aim and objectives of the study was to evaluate the association of serum lactate levels among Type 2 diabetes mellitus patients. Materials and Methods: This present observational cross-sectional study involved 300 diabetic patients who presented to the tertiary care hospital of Uttar Pradesh. The patients were stratified according to their random blood sugar, Glycated hemoglobin and lactate levels. Student t-test was used for assessing the significance, a probability of <0.05 is considered significant. Results: A total of 300 patients have been included in this study, of which 150 are males and 150 are females, the median age was 48 years. The highest age of patient included was 84 years, and the lowest of patient included in the study was 34 years. The patients with high lactate levels are found to have poor glycaemic control, which may further proceed to worst outcome of the disease. Conclusion: Serum lactate levels could be the potential predictor and reliable indicator of poor glycemic control/status of diabetic patients.
ABSTRACT
There is a strong need to search for more effective compounds with bone anti-resorptive properties,which will cause fewer complications than commonly used bisphosphonates.To achieve this goal,it is necessary to search for new techniques to characterize the interactions between bone and drug.By studying their interaction with hydroxyapatite (HA),this study used three forms of ceramic materials,two of which are bone-stimulating materials,to assess the suitability of new active substances with anti-resorptive properties.In this study,three methods based on HA in loose form,polycaprolactone/HA (a polymer-ceramic materials containing HA),and polymer-ceramic monolithic in-needle extraction(MINE) device (a polymer inert skeleton),respectively,were used.The affinity of risedronate (a standard compound) and sixteen aminomethylenebisphosphonates (new compounds with potential anti-resorptive properties) to HA was defined according to the above-mentioned methods.Ten monolithic materials based on 2-hydroxyethyl methacrylate/ethylene dimethacrylate are prepared and studied,of which one was selected for more-detailed further research.Simulated body fluids containing bisphosphonates were passed through the MINE device.In this way,sorption-desorption of bisphosphonates was evaluated using this MINE device.The paper presents the advantages and disad-vantages of each technique and its suitability for assessing new active substances.All three methods allow for the selection of several compounds with potentially higher anti-resorptive properties than risedronate,in hope that it reflects their higher bone affinity and release ability.